Accolate plus low-dose inhaled glucocorticosteroids is as effective as doubling the dose of inhaled glucocorticosteroids (Ringdal N et al., 1999).
Adapted from Ringdal et al., 1999.
References
Ringdal N, et al. Am J Respir Crit Care Med 1999; 159: A639
Accolate twice daily reduces exacerbations by over half compared to placebo (AstraZeneca data on file 04).
References
Data on file 04 – AstraZeneca Pharmaceuticals
In clinical practice Accolate has been shown to offer clear improvements in asthma when added to existing treatment (AstraZeneca data on file 01)*.
* Non-controlled trial, where Accolate was added to other medication
References
Data on file 01 – AstraZeneca Pharmaceuticals |
